Skip to main content

Funding Calls Database « All Calls

UKRI FFESDONHI

Funder(s): UK Research and Innovation,

UKRI Funding for early stage development of new healthcare interventions:
Apply for funding to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development.

The idea for a new product that can improve human health should have already been conceived and supported by other funding. This should be utilised to produce the critical preliminary data needed to support the onward development of the product.

You can apply for funding for work on novel:

  • new small molecule medicines
  • vaccines for infectious or non-infectious disease
  • biologics (antibodies, peptides, proteins)
  • advanced therapeutics (for example, gene therapy, cell therapy, RNA therapy, nucleic acid therapy and T-cell therapy)
  • complex medicines for example PROTACS, molecular glues and antibody-drug conjugates
  • regenerative medicine approaches
  • repurposing clinical studies or using existing therapies for new indications
  • medical devices
  • digital healthcare, app development or artificial intelligence
  • diagnostics (including biomarker validation)
  • medical imaging technology
  • surgical techniques or tools
  • behavioural and psychological interventions
  • radiotherapy and radiation protocols

Timeline & Milestones

Call Open

January 3, 2024

Deadline First stage (LOI / pre-proposal)

To be decided

Announcement of Applicants selected for stage 2

To be decided

Deadline Full Application

March 13, 2024

Grant Decision – Final Decision – Awarding

To be decided

Unfortunatly this funding call is not open for applications.